Showing results (141-150 of 1,725) with videos related to
Sort By:
Pageof 173
Drugs of Today (Barcelona, Spain : 1998)|April 25, 2003
Endoscopic antireflux treatment: fact, fiction or future?J Hochberger, S Tex, J Maiss, et al.Drugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Objectives and strategies for rheumatoid arthritis therapy: yesterday vs. todayJosef S SmolenDrugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Role of adalimumab, a novel TNF antagonist in advancing rheumatoid arthritis controlPaul EmeryDrugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Nesiritide in perspective: evolving approaches to the management of acute decompensated heart failureRoger M Mills, Robert E HobbsDrugs of Today (Barcelona, Spain : 1998)|June 29, 2019
Baloxavir marboxil: a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of acute uncomplicated influenzaS C Locke, L M Splawn, J C ChoDrugs of Today (Barcelona, Spain : 1998)|April 12, 2018
The year's new drugs & biologics, 2017, part II - News that shaped the industry in 2017A I Graul, C Dulsat, P Pina, et al.Drugs of Today (Barcelona, Spain : 1998)|June 6, 2018
Daclatasvir, asunaprevir and beclabuvir fixed-dose combination for patients with genotype 1 chronic hepatitis CA Thiam, B ConwayDrugs of Today (Barcelona, Spain : 1998)|June 6, 2018
Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infectionB B SummersDrugs of Today (Barcelona, Spain : 1998)|June 19, 2018
Ibrutinib for the treatment of patients with chronic graft-versus-host disease after failure of one or more lines of systemic therapyL T Rahmat, A C LoganDrugs of Today (Barcelona, Spain : 1998)|June 19, 2018
Plasmid DNA vaccines: where are we now?F GhaffarifarPageof 173